Nursing and Supply Chain as Critical Partners in Enterprise-Level Efforts to Prevent Hemodialysis Associated Central Line-Associated Blood Stream Infections: A Case Study.

HCA healthcare journal of medicine Pub Date : 2024-10-01 eCollection Date: 2024-01-01 DOI:10.36518/2689-0216.2022
Dana L Blayney, Julia Moody, James Pittman, Noah Zanville, Missy Pennington, Sarah A Fraker, E Jackie Blanchard
{"title":"Nursing and Supply Chain as Critical Partners in Enterprise-Level Efforts to Prevent Hemodialysis Associated Central Line-Associated Blood Stream Infections: A Case Study.","authors":"Dana L Blayney, Julia Moody, James Pittman, Noah Zanville, Missy Pennington, Sarah A Fraker, E Jackie Blanchard","doi":"10.36518/2689-0216.2022","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Preventing central line-associated bloodstream infections (CLABSIs) remains a critical national focus for health care facilities. This notion is particularly true for patients undergoing hemodialysis (HD), where the associated mortality rates for HD-CLABSI range from 12% to 25%. Studies show that the use of central venous catheter (CVC) end caps coated with antiseptic agents, such as chlorhexidine gluconate (CHG) on HD-CVCs, can reduce the incidence of CLABSIs. However, issues ranging from difficulty finding and maintaining an adequate (and fully standardized) supply of CHG-impregnated HD end caps and ensuring consistent practice by clinicians can prevent the use of this valuable tool. The purpose of this study is to discuss the implementation and lessons learned from a successful collaboration between supply chain and nursing standardization of the supply of CHG-impregnated HD-CVC end caps in more than 140 United States-based hospitals.</p><p><strong>Methods: </strong>The 3-year, enterprise-wide initiative to standardize supply and end cap practice as well as reduce HD CLABSIs involved 3 phases: (Phase I) piloting the change in 5 inpatient facilities; (Phase II) implementing and scaling the change across 140 hospitals; and (Phase III) stabilizing supply and hard-wiring practices.</p><p><strong>Results: </strong>Following the pilot, access to CHG-impregnated HD-CVC end caps increased more than 100-fold over the next 4 quarters, with more than 50 000 CHG HD-CVC end caps being available for use by the end of 2022. Throughout the process, review and real-time audit of HD-CVC end cap application and removal were used to standardize the practice. The review of CLABSI data over the course of the program showed a nearly 16% reduction in HD-CLABSI events per 1000 catheter days following standardization of HD-CVC end cap supply.</p><p><strong>Conclusion: </strong>Overall, our results suggest that standardizing the supply of HD-CVC end caps (which are a critical link in the infection prevention chain) was associated with a reduction in CLABSIs among patients undergoing HD. In addition, the close collaboration between supply chain and nursing was instrumental to the success of our endeavor and may serve as a model for other health systems wanting to pursue similar efforts.</p>","PeriodicalId":73198,"journal":{"name":"HCA healthcare journal of medicine","volume":"5 5","pages":"587-595"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11547290/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"HCA healthcare journal of medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36518/2689-0216.2022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Preventing central line-associated bloodstream infections (CLABSIs) remains a critical national focus for health care facilities. This notion is particularly true for patients undergoing hemodialysis (HD), where the associated mortality rates for HD-CLABSI range from 12% to 25%. Studies show that the use of central venous catheter (CVC) end caps coated with antiseptic agents, such as chlorhexidine gluconate (CHG) on HD-CVCs, can reduce the incidence of CLABSIs. However, issues ranging from difficulty finding and maintaining an adequate (and fully standardized) supply of CHG-impregnated HD end caps and ensuring consistent practice by clinicians can prevent the use of this valuable tool. The purpose of this study is to discuss the implementation and lessons learned from a successful collaboration between supply chain and nursing standardization of the supply of CHG-impregnated HD-CVC end caps in more than 140 United States-based hospitals.

Methods: The 3-year, enterprise-wide initiative to standardize supply and end cap practice as well as reduce HD CLABSIs involved 3 phases: (Phase I) piloting the change in 5 inpatient facilities; (Phase II) implementing and scaling the change across 140 hospitals; and (Phase III) stabilizing supply and hard-wiring practices.

Results: Following the pilot, access to CHG-impregnated HD-CVC end caps increased more than 100-fold over the next 4 quarters, with more than 50 000 CHG HD-CVC end caps being available for use by the end of 2022. Throughout the process, review and real-time audit of HD-CVC end cap application and removal were used to standardize the practice. The review of CLABSI data over the course of the program showed a nearly 16% reduction in HD-CLABSI events per 1000 catheter days following standardization of HD-CVC end cap supply.

Conclusion: Overall, our results suggest that standardizing the supply of HD-CVC end caps (which are a critical link in the infection prevention chain) was associated with a reduction in CLABSIs among patients undergoing HD. In addition, the close collaboration between supply chain and nursing was instrumental to the success of our endeavor and may serve as a model for other health systems wanting to pursue similar efforts.

护理和供应链是企业级预防血液透析相关中心管路血流感染工作的重要合作伙伴:案例研究。
背景:预防中心管路相关性血流感染(CLABSIs)仍然是全国医疗机构关注的重点。对于接受血液透析(HD)的患者来说,这一观念尤为重要,HD-CLABSI 的相关死亡率在 12% 到 25% 之间。研究表明,在 HD-CVC 上使用涂有消毒剂(如葡萄糖酸氯己定(CHG))的中心静脉导管(CVC)端盖可以降低 CLABSI 的发生率。然而,由于难以找到并维持充足(完全标准化)的浸渍过 CHG 的 HD 端盖供应,以及难以确保临床医生的一致操作等问题,这一宝贵工具的使用受到了阻碍。本研究旨在讨论美国 140 多家医院在供应链和护理标准化方面成功合作的经验和教训:这项为期 3 年的全企业倡议旨在实现供应和端盖实践标准化并减少 HD CLABSI,共分为 3 个阶段:(第 I 阶段)在 5 家住院机构试点变革;(第 II 阶段)在 140 家医院实施和推广变革;(第 III 阶段)稳定供应和硬连接实践:试点结束后,在接下来的 4 个季度中,CHG 浸药 HD-CVC 瓶盖的使用量增加了 100 多倍,到 2022 年底,可使用的 CHG HD-CVC 瓶盖超过 50 000 个。在整个过程中,对 HD-CVC 端盖的使用和移除进行了审查和实时审计,以规范操作。对计划实施过程中的 CLABSI 数据进行的审查显示,在实现 HD-CVC 端盖供应标准化后,每 1000 个导管日的 HD-CLABSI 事件减少了近 16%:总之,我们的研究结果表明,HD-CVC 端盖供应标准化(这是感染预防链中的关键一环)与接受 HD 治疗的患者 CLABSIs 减少有关。此外,供应链与护理之间的紧密合作也是我们取得成功的重要因素,可为其他希望开展类似工作的医疗系统树立典范。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信